[FULC] YoY Quarter Result on 31-Mar-2023 [#Q4]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
15-May-2023
Financial Year
2022
Quarter
31-Mar-2023 [#Q4]
Profit Trend
QoQ- 8.51%
YoY- 16.40%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 295 2,592 4,789 750 0 0 -
PBT -26,870 -24,779 -25,928 -16,999 -18,452 -36,843 -6,940 25.28%
Tax 435 -3,161 -70 0 0 -377 0 -
NP -26,870 -21,618 -25,858 -16,999 -18,452 -36,843 -6,940 25.28%
Tax Rate - - - - - - - -
Total Cost 26,870 21,913 28,450 21,788 19,202 36,843 6,940 25.28%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 -7,328.14 -997.61 -354.96 -2,460.27 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.43 -0.36 -0.64 -0.54 -0.81 -1.58 -0.41 0.79%
EPS Diluted -0.43 -0.36 -0.64 -0.54 -0.81 -1.58 -0.41 0.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.